Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fendo.2025.1418535.s001ObjectivesTo propose a comprehensive scoring system for adrenal tumors ≤ 6cm and evaluate its rationality and validity.Materials and methodsThis study retrospectively analyzed 268 patients with primary adrenal tumors who underwent laparoscopic surgery from January 2018 to December 2022 and all of them met the inclusion criteria. Evaluation scores were calculated for gender (G), body mass index (BMI) (B), tumor diameter (D), the relative position of the tumor to the kidney (K), the relative position of the tumor and the blood vessels (V) and the tumor location in the adrenal gland (A). Then, the total scores were correlated with the operation results, so as to verify the feasibility of GBDKVA in evaluating the surgical risk.ResultsThe GBDKVA score showed a consistent and statistically significant correlation with operation time (OT) and blood loss (BL), as well as a correlation with postoperative complications in patients (p ConclusionsGBDKVA score is reliable for preoperative risk assessment of patients with adrenal tumors ≤6cm.
Keyword(s):
adrenal tumor; Cell Metabolism; laparoscopic surgery; scoring system; surgical risks.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)